Stevens-Johnson Syndrome and Severe Anaemia: A Case of Toxicity Induced by Vemurafenib plus Cobimetinib following Pembrolizumab for Metastatic Melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Stevens-Johnson Syndrome and Severe Anaemia: A Case of Toxicity Induced by Vemurafenib plus Cobimetinib following Pembrolizumab for Metastatic Melanoma

Published:2022-02-22 Issue: Volume:102 Page:adv00650
ISSN:1651-2057
Container-title:Acta Dermato-Venereologica
language:
Short-container-title:Acta Derm Venereol

Author:

Batinac Tanja,Hlača Nika,Simetić Luka,Valković Frane,Peternel Sandra,Prpić-Massari Larisa

Abstract

Abstract is missing (Short communication)

Publisher

Medical Journals Sweden AB

Subject

Dermatology,General Medicine

Reference30 articles.

1. Heinzerling L, Eigentler TK, Fluck M, Hassel JC, Heller-Schenck D, Leipe J, et al. Tolerability of BRAF/MEK inhibitor combinations: adverse event evaluation and management. ESMO Open 2019; 4: e000491.

2. https://doi.org/10.1136/esmoopen-2019-000491

3. O'Reilly A, Larkin J. Checkpoint inhibitors in advanced melanoma: effect on the field of immunotherapy. Expert Rev Anticancer Ther 2017; 17: 647-655.

4. https://doi.org/10.1080/14737140.2017.1341315

5. Torres-Navarro I, de Unamuno-Bustos B, Botella-Estrada R. Systematic review of BRAF/MEK inhibitors-induced severe cutaneous adverse reactions (SCARs). J Eur Acad Dermatol Venereol 2021; 35: 607-614.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cobimetinib/pembrolizumab/vemurafenib;Reactions Weekly;2022-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP